Status:
COMPLETED
Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conditions:
Obstructive Sleep Apnea
Eligibility:
MALE
30-60 years
Phase:
PHASE4
Brief Summary
Recent evidences suggest that obstructive sleep apnea (OSA) can contribute to cardiovascular disease even in the absence of hypertension. However, there are few data regarding the impact of OSA on the...
Eligibility Criteria
Inclusion
- Severe OSA patients
Exclusion
- Smoking
- Sustained Hypertension
- Heart failure
- Diabetes
- Renal diseases
- Under use of any medication
- Under treatment for OSA
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00741520
Start Date
August 1 2008
End Date
July 1 2010
Last Update
October 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Institute (InCor)
São Paulo, São Paulo, Brazil, 05403-904